A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety and Efficacy of Daclizumab HYP Monotherapy in Relapsing-Remitting Multiple Sclerosis: Primary Results of the SELECT Trial (S01.005)
暂无分享,去创建一个
X. Montalban | E. Radue | R. Gold | E. Havrdová | G. Giovannoni | K. Selmaj | J. Elkins | Randy R. Robinson | G. O'neill | D. Stefoski | K. Riester